Biogen Idec will price it’s new multiple sclerosis pill, Tecfidera, at a wholesale acquisition cost of $54,900 per patient per year. The medicine will distributed, stocked, and available to patients “on or around” this coming Monday, the company says.

“We think this price represents a solid value to the MS community and demonstrates our commitment to ensuring patient access,” a company spokesperson said in a statement.




I say AAARRRGGGHHH.(note to self - better start saving now) Solid value? College a year for 2 kids cheaper.